tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tom Roderick, 60 are a HOLD (23.26%), 197 are a BUY (76.36%), 1 are a SELL (0.39%).
Analyst Tom Roderick, currently employed at STIFEL, carries an average stock price target met ratio of 82.64% that have a potential upside of 23.46% achieved within 251 days.
Tom Roderick’s has documented 503 price targets and ratings displayed on 33 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on DOX, Amdocs Ltd at 01-Oct-2024.
Analyst best performing recommendations are on MDLA (MEDALLIA).
The best stock recommendation documented was for MDLA (MEDALLIA) at 7/22/2019. The price target of $43 was fulfilled within 4 days with a profit of $7 (19.44%) receiving and performance score of 48.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Jun-2023
$225
$-17.27 (-7.13%)
$270
Buy Since 14-Dec-2023
$290
$47.73 (19.70%)
$250
29 days ago
(14-Sep-2026)
5/25 (20%)
$24.4 (9.19%)
64
Hold Since 16-Dec-2022
$250
$7.73 (3.19%)
$230
1 months 2 days ago
(11-Sep-2026)
18/23 (78.26%)
$-2.23 (-0.88%)
64
Hold Since 03-Mar-2021
$250
$7.73 (3.19%)
$301
1 months 2 days ago
(11-Sep-2026)
24/39 (61.54%)
$-2.23 (-0.88%)
95
Buy Since 12-Dec-2022
$315
$72.73 (30.02%)
$315
1 months 2 days ago
(11-Sep-2026)
5/28 (17.86%)
$62.77 (24.89%)
159
What Year was the first public recommendation made by Tom Roderick?
